-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TPW9F8/OI5OtN9aeeptIYDWoKOL8Ka+1HSxthtgI92tudZgkswkSgc4WIT3RKyVc HoFJVNERJLeV8jQ4crKbCA== 0001237899-03-000030.txt : 20031217 0001237899-03-000030.hdr.sgml : 20031217 20031217130853 ACCESSION NUMBER: 0001237899-03-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031215 FILED AS OF DATE: 20031217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOLINSKI STUART CENTRAL INDEX KEY: 0001226686 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 031059497 BUSINESS ADDRESS: STREET 1: REGENERON PHARMACEUTICALS INC STREET 2: 777 OLD SAW MILL RIVER CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2003-12-15 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226686 KOLINSKI STUART 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP, Gen Counsel & Secretary Common Stock 2003-12-15 4 A 0 6485 0 A 12145 D Incentive Stock Option (right to buy) 13 2003-12-15 4 A 0 7692 0 A 2013-12-15 Common Stock 7692 7692 D Non-Qualified Stock Option (right to buy) 13 2003-12-15 4 A 0 92308 0 A 2013-12-15 Common Stock 92308 92308 D Award of Restricted Stock under 2000 Long-Term Incentive Plan. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. **/s/Stuart Kolinski 2003-12-17 -----END PRIVACY-ENHANCED MESSAGE-----